Short description
Tumentia is a pharmaceutical company focused on the development of new therapies for cancer patients.
Description
Tumentia is a pharmaceutical company focused on the development of new therapies for cancer patients.
The company was founded by graduates of the Concordia University in Montreal, Canada & the University of Wyoming in 2014.
We develop novel therapies for cancer patients.
Our research has resulted in five pre-clinical stage drugs that treat different types of cancers.
Tumentia has been acquired by Excellence Health Inc. in October, 2017 & will now operate as a subsidiary.
Last funding
Cannot Access
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Casper, Wyoming, United States, North America
Founded on
January 1, 2014
Exited on
October 8, 2017
Non-profit?
No
Acquired?
No
Employees count
11-50